Laura Brooks

749 total citations · 1 hit paper
20 papers, 343 citations indexed

About

Laura Brooks is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Laura Brooks has authored 20 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 7 papers in Physiology. Recurrent topics in Laura Brooks's work include Asthma and respiratory diseases (7 papers), Dysphagia Assessment and Management (6 papers) and Tracheal and airway disorders (6 papers). Laura Brooks is often cited by papers focused on Asthma and respiratory diseases (7 papers), Dysphagia Assessment and Management (6 papers) and Tracheal and airway disorders (6 papers). Laura Brooks collaborates with scholars based in United States, United Kingdom and Canada. Laura Brooks's co-authors include Ubaldo J. Martin, Peter Barker, Jane Robertson, Juliane M. Jürgensmeier, Shethah Morgan, William W. Busse, Eugene R. Bleecker, Gary T. Ferguson, Paulo M. Hoff and David M. Wilson and has published in prestigious journals such as New England Journal of Medicine, Blood and Gastroenterology.

In The Last Decade

Laura Brooks

17 papers receiving 339 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis

2024 34 citations Marc E. Rothenberg, Evan S. Dellon et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Brooks United States	10	160	158	104	61	41	20	343
Courtney W. Frankel United States	9	181 1.1×	81 0.5×	189 1.8×	40 0.7×	11 0.3×	31	377
Satoshi Ikarashi Japan	11	203 1.3×	25 0.2×	275 2.6×	113 1.9×	19 0.5×	40	358
Nobuya Monden Japan	11	141 0.9×	23 0.1×	163 1.6×	130 2.1×	13 0.3×	54	357
Roció Redondo‐Rodríguez Spain	11	118 0.7×	98 0.6×	15 0.1×	14 0.2×	105 2.6×	23	255
Michèle D. Bishop United States	7	114 0.7×	17 0.1×	150 1.4×	87 1.4×	5 0.1×	8	317
Yosuke Hirasawa Japan	12	160 1.0×	59 0.4×	144 1.4×	107 1.8×	72 1.8×	30	357
Izabella Costa Santos Brazil	11	103 0.6×	79 0.5×	264 2.5×	174 2.9×	7 0.2×	31	454
Petra Neuser Germany	8	127 0.8×	52 0.3×	103 1.0×	44 0.7×	20 0.5×	16	362
L Donati Italy	6	134 0.8×	201 1.3×	47 0.5×	146 2.4×	50 1.2×	19	332
Qiang Hou United States	6	210 1.3×	69 0.4×	19 0.2×	20 0.3×	32 0.8×	17	316

Countries citing papers authored by Laura Brooks

Since Specialization

Citations

This map shows the geographic impact of Laura Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Brooks more than expected).

Fields of papers citing papers by Laura Brooks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Brooks. The network helps show where Laura Brooks may publish in the future.

Co-authorship network of co-authors of Laura Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Brooks. A scholar is included among the top collaborators of Laura Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Brooks. Laura Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Criner, Gerard J., Dave Singh, Alberto Papi, et al.. (2025). Predicting response to benralizumab in patients with COPD: a plain language summary of publication of the GALATHEA and TERRANOVA studies. Therapeutic Advances in Respiratory Disease. 19. 2693891388–2693891388.

Rothenberg, Marc E., Evan S. Dellon, Margaret H. Collins, et al.. (2024). Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. New England Journal of Medicine. 390(24). 2252–2263. 34 indexed citations breakdown →

Brooks, Laura, et al.. (2024). Thickening human milk: the effect of time, temperature, and thickener for infants with dysphagia. European Journal of Pediatrics. 183(4). 1839–1848. 3 indexed citations

Rothenberg, Marc E., Evan S. Dellon, Margaret H. Collins, et al.. (2023). 610 EFFICACY AND SAFETY OF BENRALIZUMAB IN ADULTS AND ADOLESCENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 24-WEEK DOUBLE-BLIND PERIOD OF THE PHASE 3 MESSINA TRIAL. Gastroenterology. 164(6). S–114. 8 indexed citations

Akuthota, Praveen, Amy D. Klion, Princess U. Ogbogu, et al.. (2023). The Phase 3 Natron Study Evaluating Benralizumab in Patients with Hypereosinophilic Syndrome: Study Design and Patient Characteristics. Blood. 142(Supplement 1). 1172–1172.

Brooks, Laura, et al.. (2021). Pediatric Medullary Stroke, Severe Dysphagia, and Multimodal Intervention. Dysphagia. 37(5). 1333–1336. 4 indexed citations

Busse, William W., Eugene R. Bleecker, J. Mark FitzGerald, et al.. (2021). Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment. Journal of Allergy and Clinical Immunology. 148(1). 266–271.e2. 25 indexed citations

Brooks, Laura, et al.. (2021). Thickened Liquids Using Pureed Foods for Children with Dysphagia: IDDSI and Rheology Measurements. Dysphagia. 37(3). 578–590. 19 indexed citations

Brooks, Laura, et al.. (2021). Swallowing Outcomes Following Supraglottoplasty: A Retrospective Review. The Laryngoscope. 131(12). 2817–2822. 7 indexed citations

10.

Busse, William W., Eugene R. Bleecker, J. Mark FitzGerald, et al.. (2020). Three-Year Safety and Efficacy of Benralizumab for Adolescent Patients with Severe, Uncontrolled Asthma: Results of the BORA Extension Study. Journal of Allergy and Clinical Immunology. 145(2). AB174–AB174.

11.

Brooks, Laura, et al.. (2019). Posterior Tongue Tie, Base of Tongue Movement, and Pharyngeal Dysphagia: What is the Connection?. Dysphagia. 35(1). 129–132. 11 indexed citations

12.

FitzGerald, J. Mark, Eugene R. Bleecker, Arnaud Bourdin, et al.. (2019). <p>Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma</p>. Journal of Asthma and Allergy. Volume 12. 401–413. 28 indexed citations

13.

Criner, Gerard J., Bartolomé R. Celli, Dave Singh, et al.. (2019). Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies. The Lancet Respiratory Medicine. 8(2). 158–170. 78 indexed citations

14.

Brooks, Laura, et al.. (2019). Passy muir valve tolerance in medically complex infants and children: Are there predictors for success?. The Laryngoscope. 130(11). E632–E639. 4 indexed citations

15.

FitzGerald, J. Mark, Eugene R. Bleecker, Arnaud Bourdin, et al.. (2019). Two-Year Integrated Efficacy and Safety Analysis of Benralizumab SIROCCO, CALIMA, ZONDA, and BORA Trials in Severe Asthma. A2676–A2676. 2 indexed citations

16.

Bourdin, Arnaud, Dominick Shaw, Andrew Menzies‐Gow, et al.. (2019). Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma. Journal of Asthma. 58(4). 514–522. 26 indexed citations

17.

Bar, Jair, Stuart Spencer, Shethah Morgan, et al.. (2013). Correlation of Lactate Dehydrogenase Isoenzyme Profile With Outcome in Patients With Advanced Colorectal Cancer Treated With Chemotherapy and Bevacizumab or Cediranib: Retrospective Analysis of the HORIZON I Study. Clinical Colorectal Cancer. 13(1). 46–53. 23 indexed citations

18.

Jürgensmeier, Juliane M., Hans‐Joachim Schmoll, Jane Robertson, et al.. (2013). Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. British Journal of Cancer. 108(6). 1316–1323. 50 indexed citations

19.

Smith, John, Laura Brooks, Paulo M. Hoff, et al.. (2013). KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib. European Journal of Cancer. 49(10). 2424–2432. 14 indexed citations

20.

Keegan, Achsah, Laura Brooks, & Dorothy M. Painter. (1994). Hepatic Infarction and Nodular Regenerative Hyperplasia of the Liver With Associated Anticardiolipin Antibodies in a Young Woman. Journal of Clinical Gastroenterology. 18(4). 309–313. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact